Published in Cancer Res on June 01, 1981
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists. Pharm Res (2009) 1.09
The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver. Environ Health Perspect (1983) 0.83
The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res (2012) 0.83
Anticancer activity of Cynodon dactylon L. root extract against diethyl nitrosamine induced hepatic carcinoma. South Asian J Cancer (2015) 0.78
Quantitative relationship between hepatocytic neoplasms and islands of cellular alteration during hepatocarcinogenesis in the male F344 rat. Am J Pathol (1985) 0.78
Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment. Environ Health Perspect (1993) 0.77
Effects of PCBs and related compounds on hepatocarcinogenesis in rats and mice. Environ Health Perspect (1985) 0.76
Concentration-dependent inhibition of development of GGT positive foci in rat liver by the environmental contaminant di(2-ethylhexyl) phthalate. Environ Health Perspect (1985) 0.75
Growth-related alterations during liver carcinogenesis: effect of promoters. Environ Health Perspect (1990) 0.75
In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology (1995) 3.67
Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A (1992) 2.54
Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (1990) 2.00
Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann N Y Acad Sci (2000) 1.93
Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci (1992) 1.90
Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol (1996) 1.51
DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res (1990) 1.36
Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol (1974) 1.29
Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J Cell Sci (1993) 1.25
Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis (1984) 1.24
The Fas-induced apoptosis analyzed by high throughput proteome analysis. J Biol Chem (2000) 1.20
Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res (1991) 1.20
Khat (Catha edulis) consumption causes genotoxic effects in humans. Int J Cancer (2001) 1.19
Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci U S A (1994) 1.19
Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology (1997) 1.17
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer (1993) 1.16
Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology (1993) 1.13
Tumor promotion in the liver. Arch Toxicol (1985) 1.08
Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol (2002) 1.00
Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech (2001) 0.99
Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch B Cell Pathol Incl Mol Pathol (1985) 0.99
Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth. Chem Biol Interact (1980) 0.98
Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-beta 1 occurs without activation of an endonuclease. Toxicol Lett (1992) 0.97
Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res (1983) 0.94
Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Crit Rev Toxicol (2000) 0.90
Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia. Hepatology (1998) 0.89
Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis (2001) 0.88
Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch Toxicol (1986) 0.87
[Cell proliferation and differentiation in the tracheal epithelium of the rat]. Exp Cell Res (1968) 0.87
Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis (2000) 0.86
Two-stage control of cell proliferation induced in rat liver by alpha-hexachlorocyclohexane. Cancer Res (1977) 0.86
New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis. Br J Cancer (2008) 0.85
Cytoprotective effect of the prostacyclin derivative iloprost against liver cell death induced by the hepatotoxins carbon tetrachloride and bromobenzene. Klin Wochenschr (1986) 0.85
Kinetics of DNA synthesis in feeding-dependent and independent hepatocyte populations of rats after partial hepatectomy. Cell Tissue Kinet (1983) 0.85
[Cell proliferation and differentiation in the tracheal epithelium of rats]. Exp Cell Res (1968) 0.85
Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis. Carcinogenesis (2000) 0.85
Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers. J Mol Endocrinol (2002) 0.84
Coffee consumption protects human lymphocytes against oxidative and 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate (Trp-P-2) induced DNA-damage: results of an experimental study with human volunteers. Food Chem Toxicol (2007) 0.83
Toxicological studies on a benzofurane derivative. II. Demonstration of peroxisome proliferation in rat liver. Toxicol Appl Pharmacol (1990) 0.83
Feedback inhibition of hepatic DNA synthesis. Cell Tissue Kinet (1980) 0.83
The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver. Environ Health Perspect (1983) 0.83
Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. III. Cytological changes. Chem Biol Interact (1980) 0.83
Initiation and promotion in hepatocarcinogenesis. Arch Toxicol (1987) 0.83
Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment. Crit Rev Toxicol (1997) 0.83
Induction of monooxygenases and growth in rat liver by progesterone. Arch Toxicol (1986) 0.83
Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res (1991) 0.82
Control of cell death (apoptosis) by diethylstilbestrol in an estrogen-dependent kidney tumor. Carcinogenesis (1991) 0.82
Dose-response studies on the effects of alpha-, beta-, and gamma-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver. Cancer Res (1987) 0.82
Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res (1986) 0.81
Active cell death: role in hepatocarcinogenesis and subtypes. Biochem Cell Biol (1995) 0.81
Histochemical and biochemical studies on the effect of the prostacyclin derivative iloprost on CCl4-induced lipid peroxidation in rat liver and its significance for hepatoprotection. Hepatology (1989) 0.81
Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene. Carcinogenesis (2000) 0.80
Kinetics of apoptosis and secondary necrosis in cultured rat thymocytes and S.49 mouse lymphoma and CEM human leukemia cells. Biochem Cell Biol (1995) 0.80
Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility. Toxicol Lett (2004) 0.80
[Number and "ploidy" of liver cell nuclei under the influence of substances alien to the body. Analysis by means of an electronic particle counter]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.80
Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res (1990) 0.79
Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions. Mol Carcinog (1998) 0.79
Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis (1990) 0.79
Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note. Carcinogenesis (2000) 0.78
Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis (1993) 0.78
Liver growth and mixed-function oxidase activity: dose-dependent stimulatory and inhibitory effects of alpha-hexachlorocyclohexane. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.78
Role of transforming growth factor alpha and prostaglandins in preferential growth of preneoplastic rat hepatocytes. Carcinogenesis (2001) 0.78
Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer. Carcinogenesis (1986) 0.78
Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver. Toxicol Pathol (1989) 0.78
Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis (1993) 0.78
Growth kinetics of enzyme-altered liver foci in rats treated with phenobarbital or alpha-hexachlorocyclohexane. Toxicol Appl Pharmacol (1995) 0.78
Effect of calf and rat serum on the induction of DNA synthesis and mitosis in primary cultures of adult rat hepatocytes by cyproterone acetate and epidermal growth factor. In Vitro Cell Dev Biol (1985) 0.77
Pyruvate kinase isoenzymes in altered foci and carcinoma of rat liver. Carcinogenesis (1986) 0.77
In vitro studies on subtypes and regulation of active cell death. Toxicol In Vitro (1997) 0.77
Transforming growth factor beta 1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen. Hepatology (1996) 0.77
Adaptive liver growth induced by xenobiotic compounds: its nature and mechanism. Arch Toxicol Suppl (1979) 0.77
Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma? Br J Cancer (2011) 0.77
Enhanced clastogenicity of contaminated groundwater following UV irradiation detected by the Tradescantia micronucleus assay. Mutat Res (1994) 0.77
Proliferation of rat liver cells in preneoplastic nodules after stimulation of liver growth by xenobiotic inducers. Arch Toxicol Suppl (1979) 0.77
Effect of tumor promoters on proliferation of putative preneoplastic cells in rat liver. Carcinog Compr Surv (1982) 0.77
Stimulation of cell proliferation in rat liver by alpha-hexachlorocyclohexane or partial hepatectomy and end points during G1 of the inhibitory action of beta-diethyl-aminoethylphenyldiallyl acetate-HC1 (CFT 1201), beta-diethylaminoethyldiphenylpropyl acetate. HC1 (SKF 525-A) and actinomycin D. Biochim Biophys Acta (1976) 0.77
Induction by cyproterone acetate of DNA synthesis and mitosis in primary cultures of adult rat hepatocytes in serum free medium. Arch Toxicol (1989) 0.77
Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. I. Induction of drug-metabolizing enzymes. Chem Biol Interact (1980) 0.76
Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat. Cancer Res (1991) 0.76
Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res (1991) 0.76
Chemical cancerogenesis: definitions of frequently used terms. J Cancer Res Clin Oncol (1990) 0.76